WANBURY LIMITED (WANBURY)

NSE: ₹258.15
BSE: ₹258.20
Stock Performance
Corporate Announcements
Announcement under Regulation 30 (LODR)-Press Release / Media Release

Press Release on Quality inspection by the Therapeutic Goods Administration (TGA) at Tanuku, Andhra Pradesh

2026-06-10 12:39:27
2026-06-09 13:31:14
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet – Intimation

Pursuant to Regulation 30 (6) of SEBI (Listing Obligation and Disclosure Requirements) Regulation, we wish to inform you that the Company is organizing a plant visit and management meeting of Investors/Analysts.

2026-06-02 18:39:12
Announcement under Regulation 30 (LODR)-Press Release / Media Release

Press Release on Q4 & Year ended FY 2026 for Audited Financial Results

2026-06-02 12:22:10
Outcome Of The Board Meeting Held On 29.05.2026

Outcome of the Board Meeting held on 29.05.2026

2026-05-29 21:02:24
2026-05-29 20:52:06
Update on board meeting

The Board Meeting to be held on 14/05/2026 has been revised to 29/05/2026

2026-05-12 17:16:43
Board Meeting Intimation for Notice Of Board Meeting For Approving The Audited Financial Results & Statements Of The Company For The Fourth Quarter And Year Ended 31St March, 2026.

Notice is hereby given pursuant to Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, that the meeting of the Board of Directors of Wanbury Limited is scheduled to be held on Thursday, 14th May, 2026 inter-alia, to consider and approve the Audited Financial Results & Statements for the fourth quarter and financial year ended 31st March, 2026.

2026-05-05 18:31:41
Announcement under Regulation 30 (LODR)-Press Release / Media Release

Press Release on MFDS (Ministry of Food and Drug Safety - Korea FDA) Regulatory Inspection.

2026-04-28 17:54:56
Compliances-Reg.24(A)-Annual Secretarial Compliance

Annual Secretarial Compliance Report for the Financial Year ended 31st March, 2026.

2026-04-24 18:21:43

Quarterly Financials

Consolidated Standalone
Particulars Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
Revenue from Operations 146.29 144.46 145.50 139.41 131.11 161.19 133.45 172.00 163.18 160.06 162.45 164.58
YOY Revenue Growth % 25.09% 16.54% 15.68% 4.84% -10.38% 11.58% -8.28% 23.38% 24.47% -0.7% 21.73% -4.31%
Other Income 0.62 0.76 0.69 0.93 0.94 1.63 0.84 1.84 0.35 0.20 0.18 0.21
Total Income 146.90 145.22 146.19 140.33 132.05 162.82 134.29 173.84 163.53 160.26 162.63 164.79
Total Expenses + 141.91 138.03 135.93 131.98 131.02 154.65 133.00 154.79 149.93 145.10 146.76 146.01
Cost of Materials Consumed 82.75 75.75 63.85 66.87 64.20 76.82 60.91 75.95 72.78 70.66 66.51 62.95
Employee Benefit Expense 21.08 21.07 24.63 20.14 25.15 26.35 26.31 26.42 28.69 29.43 31.84 29.68
Other Expenses 26.83 29.69 28.89 30.68 28.73 32.81 31.32 31.63 34.71 37.79 35.13 39.74
Operating Profit 4.37 6.43 9.56 7.42 0.09 6.54 0.45 17.21 13.26 14.96 15.69 18.57
OPM % 3% 4.5% 6.6% 5.3% 0.1% 4.1% 0.3% 10% 8.1% 9.3% 9.7% 11.3%
Profit Before Tax + 4.99 7.19 10.26 8.35 1.04 8.17 1.29 19.05 13.61 15.16 15.87 15.17
Tax Expense 0.30 -0.18 -0.02 0.27 0.00 0.15 0.07 -1.20 0.12 -0.02 0.11 -6.53
Tax % 6.1% -2.5% -0.2% 3.3% 0% 1.8% 5.8% -6.3% 0.8% -0.1% 0.7% -43.1%
Profit After Tax 4.69 7.36 10.27 8.08 1.04 8.02 1.22 20.26 13.49 15.18 15.76 21.70
EPS (Basic) 1.43 2.25 3.14 2.47 0.32 2.44 0.76 6.18 4.12 4.58 4.52 7.33

Yearly Financial Results

Consolidated Standalone
Particulars Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020
Revenue from Operations 650.27 599.51 575.65 499.65 511.19 392.52 367.45
YOY Revenue Growth % 8.47% 4.15% 15.21% -2.26% 30.23% 6.82% -
Other Income 0.94 3.49 2.99 0.91 1.51 2.40 1.14
Total Income 651.21 603.01 578.64 500.56 512.69 394.92 368.59
Total Expenses + 587.80 573.46 547.86 510.25 507.93 407.33 314.69
Cost of Materials Consumed 272.90 277.88 289.22 257.48 304.93 213.70 146.42
Employee Benefit Expense 119.64 104.24 86.92 81.00 74.81 64.15 67.48
Other Expenses 147.37 124.49 116.09 92.88 100.77 93.20 100.79
Operating Profit 62.47 26.06 27.79 -10.61 3.25 -14.81 52.76
OPM % 9.6% 4.3% 4.8% -2.1% 0.6% -3.8% 14.4%
Profit Before Exceptional 63.41 29.55 30.78 -9.69 4.76 -12.41 -17.97
Exceptional Items -3.60 0.00 0.00 -0.59 76.37 0.00 82.64
Profit Before Tax + 59.80 29.55 30.78 -10.29 81.13 -12.41 64.67
Tax Expense -6.33 -0.98 0.38 0.11 -0.35 0.20 64.46
Tax % -10.6% -3.3% 1.2% - -0.4% - 99.7%
Profit After Tax 66.13 30.53 30.40 -10.40 81.47 -12.61 0.21
EPS (Basic) 20.55 9.32 9.29 -6.18 26.88 -5.04 26.90

Balance Sheet

Particulars Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020
ASSETS
Non-Current Assets + 279.11 220.47 184.21 179.74 179.34 187.91 0.00
Property, Plant & Equipment 226.51 189.69 149.02 151.50 148.71 158.11 0.00
Capital Work in Progress 25.42 5.38 3.01 1.61 2.35 11.01 0.00
Non-Current Investments 0.03 0.02 0.03 0.01 0.01 0.01 0.00
Goodwill 0.00 10.68 0.00 0.00 0.00 0.00 0.00
Other Intangible Assets 2.71 0.23 0.27 0.09 0.10 0.23 0.00
Current Assets + 238.56 193.44 159.29 120.54 169.69 95.95 0.00
Inventories 50.63 37.68 36.02 21.99 49.73 24.85 0.00
Trade Receivables 143.28 114.16 89.44 67.98 62.80 34.47 0.00
Cash and Cash Equivalents 1.61 4.06 3.40 1.46 22.49 9.96 0.00
Current Investments 0.00 0.13 0.00 0.00 0.00 0.00 0.00
LIABILITIES & EQUITY
Total Equity 144.45 59.27 27.94 -7.26 2.19 -130.66 0.00
Equity Share Capital 34.94 32.77 32.75 32.71 32.67 25.02 0.00
Other Equity 109.51 26.50 -4.80 -39.96 -30.48 -155.67 0.00
Non-Current Liabilities 172.18 180.03 101.45 16.31 16.20 90.07 0.00
Current Liabilities 201.04 174.61 214.11 293.19 332.62 328.19 0.00
Total Liabilities 373.22 354.65 315.55 309.50 348.81 418.26 0.00

Cash Flow Statement

Particulars Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020
Cash from Operating Activities 31.53 26.10 4.02 19.80 37.56 16.68 0.00
Cash from Investing Activities -56.40 -51.17 -16.63 -8.84 0.59 8.04 0.00
Cash from Financing Activities 22.42 25.73 14.55 -31.99 -25.62 -17.39 0.00
Net Increase/Decrease in Cash -2.45 0.66 1.94 -21.03 12.53 7.34 0.00